Rufinamide Tablets
cGMP deviations: Batch was released prior to approval.
207 recalls, newest first
cGMP deviations: Batch was released prior to approval.
CGMP deviation: product released prior to supplier approval.
cGMP deviations: due to shipment of rejected units.
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
CGMP Deviations: use of non-food grade lubricant in mixing vessel.
CGMP Deviations: use of non-food grade lubricant in mixing vessel.
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.